Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-20 Sale |
2025-02-24 6:57 pm |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
47,600 | $60.22 | $2,866,534 | 82,944 (Direct) |
View |
2025-02-14 Sale |
2025-02-19 4:49 pm |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
400 | $60 | $24,000 | 130,544 (Direct) |
View |
2025-02-10 Sale |
2025-02-12 7:59 pm |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
175,000 | $54.46 | $9,530,351 | 130,944 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-16 Option Award |
2024-05-17 4:07 pm |
N/A 2034-05-16 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
16,311 | $0 | 318,160 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 5:02 pm |
N/A 2033-06-13 |
2seventy bio Inc. | TSVT | LYNCH DANIEL Director |
25,300 | $0 | 37,953 (Direct) |
View |
2023-05-24 Option Award |
2023-05-25 4:28 pm |
N/A 2033-05-24 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
18,422 | $0 | 315,623 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 6:20 pm |
N/A 2032-06-08 |
2seventy bio Inc. | TSVT | LYNCH DANIEL Director |
21,600 | $0 | 27,053 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:43 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
20,136 | $0 | 312,519 (Direct) |
View |
2021-11-11 Other |
2021-11-17 08:57 am |
N/A 2023-01-16 |
bluebird bio Inc. | BLUE | LYNCH DANIEL Director |
77,942 | $0 | 77,801 (Direct) |
View |
2021-11-11 Option Award |
2021-11-16 06:44 am |
N/A 2023-01-16 |
2seventy bio Inc. | TSVT | LYNCH DANIEL Director |
30,586 | $0 | 33,236 (Direct) |
View |
Ownership |
2021-10-21 8:39 pm |
N/A 2030-07-22 |
Xilio Therapeutics Inc. | XLO | LYNCH DANIEL Director 10% Owner |
0 | $0 | 335,394 (Direct) |
View |
2021-06-15 Option Award |
2021-06-17 4:08 pm |
N/A 2031-06-15 |
bluebird bio Inc. | BLUE | LYNCH DANIEL Director |
11,353 | $0 | 19,312 (Direct) |
View |
2021-05-20 Option Award |
2021-05-21 4:31 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
8,104 | $0 | 299,381 (Direct) |
View |
2020-12-17 Ownership |
2021-02-16 4:12 pm |
N/A N/A |
Translate Bio Inc. | TBIO | LYNCH DANIEL Director |
100,000 | $0 | 221,825 (Direct) |
View |
2020-12-08 Ownership |
2021-02-11 4:30 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
100,000 | $0 | 459,577 (Direct) |
View |
Ownership |
2021-01-06 9:42 pm |
N/A N/A |
Omega Alpha SPAC | OMEG | LYNCH DANIEL Director |
0 | $0 | 35,000 (Direct) |
View |
2020-06-24 Option Award |
2020-06-26 4:08 pm |
N/A 2030-06-24 |
Blueprint Medicines Corp | BPMC | LYNCH DANIEL Director |
6,750 | $0 | 132,404 (Direct) |
View |
2020-06-19 Exercise |
2020-06-23 4:18 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | LYNCH DANIEL Director |
1,312 | $0 | 125,654 (Direct) |
View |
2020-06-18 Option Award |
2020-06-22 4:27 pm |
N/A 2030-06-18 |
bluebird bio Inc. | BLUE | LYNCH DANIEL Director |
6,559 | $0 | 12,159 (Direct) |
View |
2020-06-16 Option Award |
2020-06-17 5:52 pm |
N/A 2030-06-15 |
Translate Bio Inc. | TBIO | LYNCH DANIEL Director |
18,900 | $0 | 18,900 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 08:00 am |
N/A 2030-06-10 |
Surface Oncology Inc. | SURF | LYNCH DANIEL Director |
12,000 | $0 | 12,000 (Direct) |
View |
2020-05-20 Option Award |
2020-05-22 4:37 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director 10% Owner |
7,464 | $0 | 7,464 (Direct) |
View |